Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo

被引：0
|
作者：
Hrzenjak, A. [1 ]
Moinfar, F. [2 ]
Kremser, M. L. [2 ]
Strohmeier, B. [2 ]
Petru, E. [3 ]
Zatloukal, K. [2 ]
Denk, H. [2 ]
机构：
[1] Med Univ Graz, Inst Internal Med, Clin Dept Pulmonol, Graz, Austria
[2] Med Univ Graz, Dept Pathol, Graz, Austria
[3] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)71055-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
248
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [21] Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug
    Paul A Marks
    Ronald Breslow
    Nature Biotechnology, 2007, 25 : 84 - 90
  • [22] Dimethyl sulfoxide to vorinostat: Development of this histone deacetylase inhibitor as an anticancer drug
    Marks, Paul A.
    Breslow, Ronald
    NATURE BIOTECHNOLOGY, 2007, 25 (01) : 84 - 90
  • [23] Antiproliferative and proapoptotic effects of histone deacetylase inhibitor vorinostat in human melanoma
    Nihal, M.
    Wood, G. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S225 - S225
  • [24] The Histone Deacetylase Inhibitor Vorinostat Selectively Sensitizes Fibrosarcoma Cells to Chemotherapy
    Sampson, Erik R.
    Amin, Vinit
    Schwarz, Edward M.
    O'Keefe, Regis J.
    Rosier, Randy N.
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2011, 29 (04) : 623 - 632
  • [25] Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer
    Dovzhanskiy, Dmitriy I.
    Arnold, Stefanie M.
    Hackert, Thilo
    Oehme, Ina
    Witt, Olaf
    Felix, Klaus
    Giese, Nathalia
    Werner, Jens
    BMC CANCER, 2012, 12
  • [26] The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
    Jones, Jon
    Juengel, Eva
    Mickuckyte, Ausra
    Hudak, Lukasz
    Wedel, Steffen
    Jonas, Dietger
    Blaheta, Roman
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (8B) : 2376 - 2385
  • [27] Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer
    Dmitriy I Dovzhanskiy
    Stefanie M Arnold
    Thilo Hackert
    Ina Oehme
    Olaf Witt
    Klaus Felix
    Nathalia Giese
    Jens Werner
    BMC Cancer, 12
  • [28] The mechanism of Histone deacetylase inhibitor (Suberoylanilide hydroxamic acid) suppresses pancreatic cancer in vitro
    Yang, Bo
    Li, Shengze
    Zhou, Quansheng
    Cao, Cong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S44 - S44
  • [29] Histone deacetylase inhibitor MPT0B291 suppresses Glioma Growth in vitro and in vivo partially through acetylation of p53
    Buyandelger, Batsaikhan
    Bar, Eli E.
    Hung, Kuo-Sheng
    Chen, Ruei-Ming
    Chiang, Yung-Hsiao
    Liou, Jing-Ping
    Huang, Huei-Mei
    Wang, Jia-Yi
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (16): : 3184 - 3199
  • [30] Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deacetylase
    Yamano, T
    Ura, K
    Morishita, R
    Nakajima, H
    Monden, M
    Kaneda, Y
    MOLECULAR THERAPY, 2000, 1 (06) : 574 - 580
12345